These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 1263082)
1. Dissolution rates of high energy sulfathiazole--povidone coprecipitates II: characterization of form of drug controlling its dissolution rate via solubility studies. Simonelli AP; Mehta SC; Higuchi WI J Pharm Sci; 1976 Mar; 65(3):355-61. PubMed ID: 1263082 [TBL] [Abstract][Full Text] [Related]
4. Dissolution rates of high energy polyvinylpyrrolidone (PVP)-sulfathiazole coprecipitates. Simonelli AP; Mehta SC; Higuchi WI J Pharm Sci; 1969 May; 58(5):538-49. PubMed ID: 5796439 [No Abstract] [Full Text] [Related]
5. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone. Caron V; Tajber L; Corrigan OI; Healy AM Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367 [TBL] [Abstract][Full Text] [Related]
6. Polymorph farming of acetaminophen and sulfathiazole on a chip. Lee T; Hung ST; Kuo CS Pharm Res; 2006 Nov; 23(11):2542-55. PubMed ID: 16969701 [TBL] [Abstract][Full Text] [Related]
7. Amorphous is not always better-A dissolution study on solid state forms of carbamazepine. Jensen LG; Skautrup FB; Müllertz A; Abrahamsson B; Rades T; Priemel PA Int J Pharm; 2017 Apr; 522(1-2):74-79. PubMed ID: 28263832 [TBL] [Abstract][Full Text] [Related]
8. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats. Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980 [TBL] [Abstract][Full Text] [Related]
9. Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility. Marsac PJ; Shamblin SL; Taylor LS Pharm Res; 2006 Oct; 23(10):2417-26. PubMed ID: 16933098 [TBL] [Abstract][Full Text] [Related]
10. Enhancement of dissolution rates of poorly water-soluble drugs by crystallization in aqueous surfactant solutions I: Sulfathiazole, prednisone, and chloramphenicol. Chiou WL; Chen SJ; Athanikar N J Pharm Sci; 1976 Nov; 65(11):1702-4. PubMed ID: 994008 [TBL] [Abstract][Full Text] [Related]
11. Solubility advantage from amorphous etoricoxib solid dispersions. Dani P; Puri V; Bansal AK Drug Dev Ind Pharm; 2014 Jan; 40(1):92-101. PubMed ID: 23301771 [TBL] [Abstract][Full Text] [Related]
12. Effect of polyethylene glycol 4000 on dissolution properties of sulfathiazole polymorphs. Niazi S J Pharm Sci; 1976 Feb; 65(2):302-4. PubMed ID: 1255470 [TBL] [Abstract][Full Text] [Related]
13. Solubility of crystalline organic compounds in high and low molecular weight amorphous matrices above and below the glass transition by zero enthalpy extrapolation. Amharar Y; Curtin V; Gallagher KH; Healy AM Int J Pharm; 2014 Sep; 472(1-2):241-7. PubMed ID: 24968139 [TBL] [Abstract][Full Text] [Related]
14. Wetting Kinetics: an Alternative Approach Towards Understanding the Enhanced Dissolution Rate for Amorphous Solid Dispersion of a Poorly Soluble Drug. Verma S; Rudraraju VS AAPS PharmSciTech; 2015 Oct; 16(5):1079-90. PubMed ID: 25672820 [TBL] [Abstract][Full Text] [Related]
15. Effects of tablet formulation and subsequent film coating on the supersaturated dissolution behavior of amorphous solid dispersions. Sakai T; Hirai D; Kimura SI; Iwao Y; Itai S Int J Pharm; 2018 Apr; 540(1-2):171-177. PubMed ID: 29447848 [TBL] [Abstract][Full Text] [Related]
16. Understanding the generation and maintenance of supersaturation during the dissolution of amorphous solid dispersions using modulated DSC and Baghel S; Cathcart H; O'Reilly NJ Int J Pharm; 2018 Jan; 536(1):414-425. PubMed ID: 29183857 [TBL] [Abstract][Full Text] [Related]
17. Characterization of Supersaturated Danazol Solutions - Impact of Polymers on Solution Properties and Phase Transitions. Jackson MJ; Kestur US; Hussain MA; Taylor LS Pharm Res; 2016 May; 33(5):1276-88. PubMed ID: 26892947 [TBL] [Abstract][Full Text] [Related]
19. A comparative assessment of solubility advantage from glassy and crystalline forms of a water-insoluble drug. Chawla G; Bansal AK Eur J Pharm Sci; 2007 Sep; 32(1):45-57. PubMed ID: 17618092 [TBL] [Abstract][Full Text] [Related]
20. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels. Sun DD; Ju TC; Lee PI Eur J Pharm Biopharm; 2012 May; 81(1):149-58. PubMed ID: 22233548 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]